Why in News: Union Commerce and Industry Minister Piyush Goyal announced on April 17, 2026, that patent application filings in India rose 30.2% to a record 1,43,729 in FY 2025–26, up from 1,10,375 in FY 2024–25. Domestic filings reached 99,721 — accounting for 69.4% of total filings, up from 61.8% the previous year. The growth reflects the maturing of India’s R&D ecosystem and the cumulative impact of administrative reforms at the Indian Patent Office.
The Headline Numbers
| Metric | FY 2024–25 | FY 2025–26 | Change |
|---|---|---|---|
| Total filings | 1,10,375 | 1,43,729 | +30.2% |
| Domestic filings | 68,201 | 99,721 | +46.2% |
| Foreign filings | 42,174 | 44,008 | +4.3% |
| Domestic share | 61.8% | 69.4% | +7.6 pp |
The headline numbers reveal domestic filings as the primary growth engine — Indian inventors and corporations are filing patents at significantly higher rates than foreign applicants seeking Indian patent protection.
What Is Driving the Surge?
1. The Indian Patent Office Modernisation
The Office of the Controller General of Patents, Designs & Trademarks (CGPDTM) under the Department for Promotion of Industry and Internal Trade (DPIIT) has implemented major modernisation:
- Faster examination — average time from filing to first examination report reduced from over 5 years (pre-2016) to under 18 months in 2026.
- Digital filing — over 95% of patent applications filed electronically.
- AI-assisted prior art search — pilot deployment to assist examiners in identifying prior art.
- Examiner recruitment — patent examiner cadre expanded significantly post-2017.
2. The Startup India IPR Fee Waiver
Under the Startup India Action Plan (2016), recognised startups receive:
- 80% rebate on patent filing fees (₹8,000 vs ₹40,000 for large entities).
- Free legal facilitation through empanelled patent agents.
- Fast-track examination for startup patent applications.
This has dramatically lowered the cost barrier for early-stage Indian innovation.
3. Domestic R&D Ecosystem Maturity
India’s R&D landscape has matured:
- Indian universities — IITs, IISc, IISER campuses filing significantly more patents.
- Domestic pharma R&D — companies like Sun Pharma, Dr. Reddy’s, Cipla, Biocon, Lupin filing in biosimilars, novel drug delivery, formulations.
- Tech sector — Indian software product companies (not just service exporters) filing in AI, machine learning, fintech.
- Manufacturing R&D — particularly in EV batteries, defence electronics, semiconductor design (linked to PLI schemes).
4. Government Policy Push
Multiple policy interventions have contributed:
| Policy | Impact |
|---|---|
| National IPR Policy 2016 | Strategic framework for IP creation, commercialisation, enforcement |
| Patent (Amendment) Rules 2024 | Streamlined filing, expedited examination expansion |
| Startup India | Fee waivers, fast-track facilitation |
| Atmanirbhar Bharat | Domestic R&D incentives across sectors |
| Anusandhan National Research Foundation (NRF) | Established 2023 for R&D ecosystem support |
| Production Linked Incentive (PLI) Schemes | Indirect IP creation incentive |
What Patents Are Being Filed?
The composition of Indian patent filings has shifted:
- Pharmaceuticals & biotechnology — historically dominant; remains a leading category.
- Computer & electronics — fastest-growing category; reflects software product creation.
- Mechanical engineering — automotive components, EV, manufacturing equipment.
- Chemistry — specialty chemicals, agrochemicals, materials.
- Defence & aerospace — DRDO and private defence contractors filing in indigenous platforms.
India’s Position in Global Patent Rankings
In international comparisons:
- WIPO Global Innovation Index (GII) 2024: India ranked 39th globally — up from 81st in 2015.
- WIPO patent application data: India has been the fastest-growing major patent jurisdiction globally for several consecutive years.
- India’s PCT (Patent Cooperation Treaty) filings — Indian residents are filing more international patent applications, indicating cross-border commercialisation intent.
However, India still trails the absolute leaders:
- China: ~1.5 million patent filings annually
- USA: ~600,000+ patent filings
- Japan, South Korea, Europe: Each well above India’s volume
The gap is narrowing but remains substantial. India’s strength is in growth rate and trajectory more than absolute volume.
The Quality Question
Quantity of patent filings does not equal quality. Key quality indicators:
| Indicator | India’s Position |
|---|---|
| Patent grant rate | Improving but lower than US/EU |
| PCT international filings | Growing but small share of total |
| Patent commercialisation rate | Lower than peers — many granted patents not commercially exploited |
| University-industry technology transfer | Weak; Indian universities patent more than they license |
| Patent litigation depth | Limited specialised IP courts; cases pending for years |
The Domestic R&D Spending Gap
Despite the patent filing surge, India’s gross R&D spending remains low:
- R&D as % of GDP: ~0.65% (2024) vs world average ~2.7%.
- Compared to South Korea (4.8%), Israel (5.4%), USA (3.4%), China (2.4%) — India significantly lags.
- The Anusandhan National Research Foundation (NRF) Act, 2023 aims to mobilise ₹50,000 crore over 5 years (2023–28), with 70% from private and philanthropic sources.
The patent filing surge thus reflects rising R&D output efficiency rather than R&D spending volume.
Way Forward
For India to translate the patent filing surge into innovation outcomes:
- R&D spending expansion — moving from 0.65% to 2% of GDP requires sustained government and private investment.
- University tech transfer — institutionalising patent commercialisation offices in IITs, IISc, NITs.
- Specialised IP courts — faster patent litigation resolution; the Madras High Court IP Division is a model worth scaling.
- PCT filing support — incentives for Indian residents to file international applications, securing global market protection.
- SME innovation support — extending Startup India-style fee waivers to small and medium enterprises.
UPSC Relevance
| Paper | Angle |
|---|---|
| GS-3 — Science & Technology | IP regime, patent system, R&D ecosystem, innovation policy, NRF |
| GS-3 — Economy | Innovation-led growth, Startup India, Atmanirbhar Bharat, PLI schemes |
| GS-2 — Governance | Indian Patent Office reform, CGPDTM, DPIIT, regulatory modernisation |
| GS-2 — IR | TRIPS Agreement, WIPO, India’s IP positioning in international forums |
| Mains Keywords | Indian Patent Office, CGPDTM, DPIIT, National IPR Policy 2016, Startup India, NRF, R&D as percentage of GDP, WIPO GII, PCT, TRIPS |
Facts Corner
| Item | Detail |
|---|---|
| FY26 total patent filings | 1,43,729 |
| FY25 total patent filings | 1,10,375 |
| YoY growth | +30.2% |
| FY26 domestic filings | 99,721 |
| Domestic filing share | 69.4% (up from 61.8%) |
| Patent regulatory body | CGPDTM, under DPIIT |
| Examination time (current) | <18 months (vs 5+ years pre-2016) |
| Startup India IPR rebate | 80% on patent filing fees |
| India GII Rank 2024 | 39th globally |
| India R&D spending (% GDP) | ~0.65% (vs world avg 2.7%) |
| NRF Act | 2023 — ₹50,000 crore mobilisation target by 2028 |
